Sirnaomics Ltd. (2257.HK)
Develops RNA-based drugs targeting cancer, heart disease, and blood clotting disorders in China.
3.90-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-51.8%
The outlook
Sirnaomics is trading near its 52-week low, well below both its 50- and 200-day moving averages, reflecting a weak recent trend. Analyst coverage shows an average price target roughly 17.5x the current price, though this large gap suggests highly speculative positioning. Overall sentiment data leans bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +1750% vs current price
Market cap
$424.7M
52-wk high
22.78
52-wk low
3.73
50-day avg
4.91
200-day avg
7.13
Trailing P/E
—